基于HIS真实世界的参麦注射液临床实效研究

目的:基于"HIS"真实世界研究参麦注射液临床应用实际情况。方法:对全国20家三级甲等医院"HIS"中使用参麦注射液的患者信息进行分析,涵盖年龄、性别、职业、入院病情、住院天数、中西医诊断、用药剂量、给药途径、联合用药等多项指标。结果:患者年龄以46～65岁之间为最多,住院天数以15～28 d居多,冠心病、高血压病、心律失常、心功能不全等是使用参麦注射液患者较常见的疾病,约97.55%的医嘱记录符合说明书给药途径,并分析出参麦注射液辅助治疗肿瘤、休克、冠心病等联合用药。结论:参麦注射液是临床应用较多且适应症较广的一种中药注射剂,基于"HIS"得出的研究结果客观真实,为前瞻性研究及临床实际提供借鉴。

Clinical outcomes research of Shenmai injection based on hospital information system

Objective: To research the actual clinical applications of Shenmai injection based on the real world-HIS(hospital information system). Method: The data of patients injected with Shenmai is analyzed. This information is collected from HIS in twenty hospitals of grade III-A.Many indexes are included such as age, sex, occupation, admission condition, hospitalization days, critical days, diagnosis of traditional and western medicine, dosage of drug,route of administration,drug combination and so on. Result: The age of patients between 46 and 65 is the most. The hospitalization day between 15 and 28 is the most. The Shenmai injection is more used for such diseases as coronary heart disease, hypertension, arrhythmia, cardiac insufficiency. About 97.55% of route of administration in medical order are consistent with specification. The main combination drugs of Shenmai injection are analyzed for adjuvant therapy of tumor, shock and coronary heart disease. Conclusion: The Shenmai injection, as a traditional Chinese medicine injection, has the advantages of extensive indication and is used widely in clinical. The researching result based on HIS is objective and real. It can be referenced by researchers and clinician.